At ILSI, we bring science and research to diverse audiences through a wide range of events. From independent symposia and workshops to hands-on training sessions, we host, sponsor, and co-organize events that foster learning and collaboration. Many of ILSI's events are also featured as part of larger scientific and professional conferences, further expanding opportunities for engagement, dialogue, and discovery. Join us!
ILSI Southeast Asia Region and the Department of Metabolism, Nutrition and Health, Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore are hosting a guest lecture by Prof. Dr. Sunil Wimalawansa to share the latest insights on vitamin D and CVD, and its implications in Asia.
This one-day analytical workshop aims to shed light on the current state of the art in microplastics analytics and to stimulate discussion on future challenges in this rapidly evolving field
The role of vitamin D in reducing cardiovascular disease (CVD) risk remains debated despite growing evidence, with observational studies consistently linking low serum vitamin D levels with higher CVD risk. Its role in modulating inflammation and oxidative stress, improving endothelial function, and reducing cardiometabolic risk factors supports a comprehensive, multi-modal approach to cardiovascular health. In Singapore, 30-50% of the population, with prevalence higher in Malay ethnic groups, indoor workers etc., remains vitamin D deficient or insufficient despite year-round sunshine.
ILSI Southeast Asia Region and the Department of Metabolism, Nutrition and Health, Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore are hosting a guest lecture by Prof. Dr. Sunil Wimalawansa to share the latest insights on vitamin D and CVD, and its implications in Asia.
ABOUT THE SPEAKER
Prof Dr Sunil J. Wimalawansa
Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA
Prof Dr Sunil Wimalawansa is a globally renowned expert in endocrinology, osteoporosis and metabolic bone diseases, as well as nutrition and vitamin D. A clinician-scientist with more than three decades of experience, he has served on the scientific review committee of the US NIH and was a past board member of the American Association for Endocrinology.
Prof Dr Sunil J. Wimalawansa, Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA
Prof. Dr. Wimalawansa is a Professor of Medicine, Director of the CardioMetabolic & Endocrine Institute, and formerly University Professor and Chief of Endocrinology, Metabolism & Nutrition, UMDNJ/Rutgers University. His PhD from the University of London(UK) is in endocrine pathology. Dr. Wimalawansa is globally renowned in endocrinology, with broad expertise in internal medicine, endocrinology, osteoporosis and metabolic bone diseases, chronic kidney disease, nutrition, vitamin D, water and sanitation, and environmental issues. He is a clinician-scientist with more than three decades of experience, a faculty member, medical educator, author, researcher, innovator, administrator, leader, and philanthropist.
He has served on several national and international scientific review committees, including the US NIH, the US Veterans Administration, the Drug Enforcement Agency, and NASA. He is a past board member of the American Association for Endocrinology (AACE/national organization) (2011-2015) and the International Society for Clinical Densitometry (ISCD).
Dr. Wimalawansa has published over 300 peer-reviewed research articles (11,100+ citations; h-Index of 40), 45 reviews and proceedings, 15 book chapters, and 5 medical books. He holds five medical patents in cardiovascular, osteoporosis, and preeclampsia of pregnancy. He is the author of the book, "Vitamin D: Everything You Need to Know" (2012).
He has made several seminal contributions to medicine, medical research, public health, and pharmaceuticals. These include development of novel modes of treating osteoporosis, including combination therapies (1985), nitroglycerine (1987), once-a-week bisphosphonates therapy (1995), and a technique to enhance the efficacy of bisphosphonates (1997); and cost-effective therapies, such as nitric oxide donor treatment (e.g., topical nitroglycerine and oral nitrates; 1987) and vitamin E regimens for treating osteoporosis (1997).
REGISTRATION
This symposium offers complimentary registration. Due to limited seating, early registration is highly encouraged. Register now by clicking the button below:
This one-day analytical workshop aims to shed light on the current state of the art in microplastics analytics and to stimulate discussion on future challenges in this rapidly evolving field. One of the key objectives is to advance quantitative exposure assessment in relation to foods and beverages, and to discuss future challenges in this young evolving field. This workshop offers a unique opportunity for professionals from academia, industry, and the public sector to exchange ideas, engage in meaningful discussions, and build valuable cross-disciplinary connections.
Programme
10:00 - Dr. Isabelle Guelinckx (ILSI Europe), Introduction to ILSI Europe
10:10 - Todd Guin (TG Environmental Research), Introduction to Microplastics Initiative & workshop objectives
10:20 - Dr.Dieter Fischer (Leibniz Institute of Polymer Research Dresden), Dr.Eva Vizsolyi (OFI), Dr. Nadiia Yakovenko (Microplastics Solution), Dr.Christoph Kappacher (MiqaLab), Current state of art of microplastics analytics
11:40 - Dr. Pietro Gucciardi (CNR), Touching base to 2025 EFSA supporting publication and methods like Raman Technique in MiP detection in foods & beverages
12:20 - Panel discussion
13:00 - Lunch & networking break
14:30 - Breakout rooms
16:30 - Next steps & conclusions
A key outcome of the workshop will lead to the development of a peer-reviewed scientific publication, as well as the further analysis and refinement of the content for a future research proposal - an activity to be initiated in 2026.
Registration
Attendance is limited to stakeholders in microplastics analytics. Free attendance to this workshop is reserved for ILSI Europe members and experts from Academia and the Public Sector. Industry participants from non-ILSI Europe member companies wishing to join are welcome for a fee of €250.
The role of vitamin D in reducing cardiovascular disease (CVD) risk remains debated despite growing evidence, with observational studies consistently linking low serum vitamin D levels with higher CVD risk. Its role in modulating inflammation and oxidative stress, improving endothelial function, and reducing cardiometabolic risk factors supports a comprehensive, multi-modal approach to cardiovascular health. In Singapore, 30-50% of the population, with prevalence higher in Malay ethnic groups, indoor workers etc., remains vitamin D deficient or insufficient despite year-round sunshine.
ILSI Southeast Asia Region and the Department of Metabolism, Nutrition and Health, Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), Singapore are hosting a guest lecture by Prof. Dr. Sunil Wimalawansa to share the latest insights on vitamin D and CVD, and its implications in Asia.
ABOUT THE SPEAKER
Prof Dr Sunil J. Wimalawansa
Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA
Prof Dr Sunil Wimalawansa is a globally renowned expert in endocrinology, osteoporosis and metabolic bone diseases, as well as nutrition and vitamin D. A clinician-scientist with more than three decades of experience, he has served on the scientific review committee of the US NIH and was a past board member of the American Association for Endocrinology.
Prof Dr Sunil J. Wimalawansa, Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA
Prof. Dr. Wimalawansa is a Professor of Medicine, Director of the CardioMetabolic & Endocrine Institute, and formerly University Professor and Chief of Endocrinology, Metabolism & Nutrition, UMDNJ/Rutgers University. His PhD from the University of London(UK) is in endocrine pathology. Dr. Wimalawansa is globally renowned in endocrinology, with broad expertise in internal medicine, endocrinology, osteoporosis and metabolic bone diseases, chronic kidney disease, nutrition, vitamin D, water and sanitation, and environmental issues. He is a clinician-scientist with more than three decades of experience, a faculty member, medical educator, author, researcher, innovator, administrator, leader, and philanthropist.
He has served on several national and international scientific review committees, including the US NIH, the US Veterans Administration, the Drug Enforcement Agency, and NASA. He is a past board member of the American Association for Endocrinology (AACE/national organization) (2011-2015) and the International Society for Clinical Densitometry (ISCD).
Dr. Wimalawansa has published over 300 peer-reviewed research articles (11,100+ citations; h-Index of 40), 45 reviews and proceedings, 15 book chapters, and 5 medical books. He holds five medical patents in cardiovascular, osteoporosis, and preeclampsia of pregnancy. He is the author of the book, "Vitamin D: Everything You Need to Know" (2012).
He has made several seminal contributions to medicine, medical research, public health, and pharmaceuticals. These include development of novel modes of treating osteoporosis, including combination therapies (1985), nitroglycerine (1987), once-a-week bisphosphonates therapy (1995), and a technique to enhance the efficacy of bisphosphonates (1997); and cost-effective therapies, such as nitric oxide donor treatment (e.g., topical nitroglycerine and oral nitrates; 1987) and vitamin E regimens for treating osteoporosis (1997).
REGISTRATION
This symposium offers complimentary registration. Due to limited seating, early registration is highly encouraged. Register now by clicking the button below:
This site uses cookies to provide you with a personalized browsing experience. By clicking “I Agree” or continuing to use the site you agree to allow cookies to be placed and accept the terms set out in our [Privacy Notice]. Please read the Privacy Notice for more information on how we handle information collected from users and how you can control the use of such information.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Prof Dr Sunil J. Wimalawansa, Professor of Medicine, Endocrinology & Nutrition; Director, Cardio-Metabolic & Endocrine Institute, New Jersey, USA 
